Exploring the potential molecular mechanism of Gualou Guizhi decoction in the treatment of rheumatoid arthritis based on network pharmacology and molecular docking

Zhihao Duan,Can Jin,Shuai Ma,Jinlang Liu,Shigang Li,You Zhou
DOI: https://doi.org/10.1097/md.0000000000036844
IF: 1.6
2024-01-11
Medicine
Abstract:Rheumatoid arthritis (RA) is a systemic autoimmune disease that involves chronic inflammation of multiple joints. The obvious histopathological changes in RA patients are persistent inflammation and cell proliferation in the synovial membrane, various inflammatory cell infiltrates, vascular opacification formation, articular cartilage damage and bone matrix destruction, joint swelling and morning stiffness, and ultimately joint deformity and loss of function. Based on the clinical manifestations and signs of RA, it is now considered to belong to the category of "paralysis" in Chinese medicine. [ 1 , 2 ] RA affects 0.5% to 1% of today population, and to date, RA cannot be completely cured; current clinical medications can only relieve pain or reduce the progression of inflammation, with poor therapeutic effects and many side effects from long-term use. [ 3 , 4 ] Therefore, finding therapeutic agents with clear efficacy and few side effects remains a challenge for medical practitioners.
medicine, general & internal
What problem does this paper attempt to address?